CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos share insights at the STAT Breakthrough Summit East. Topics include gene therapy costs, GLP-1 story twists, and a pie contest. The discussion also covers the future of healthcare, interdisciplinary teamwork in research, innovative allergy treatments, and muscle growth potential with medication.
Regeneron aims to improve obesity treatments by preserving muscle mass while reducing body fat using a combination of muscle-boosting and weight-reducing medications.
Feng Zhang's journey from biology-averse student to CRISPR pioneer is fueled by 'Jurassic Park' inspiration, showcasing the impact of unconventional beginnings on groundbreaking scientific advancements.
Deep dives
Podcast Recap and Overview
The podcast episode of The Readout Loud features a live recording from an event in New York City where experts like Feng Zhang and George Church discuss the future of medicine. The hosts also highlight the latest news in life sciences, covering topics such as the GOP one story, gene therapy costs, and even a pie contest. The episode delves into the implications of CMS covering obesity products based on their medical benefits, despite potential costs to the federal government.
Regeneron's Innovative Approach to Obesity Drugs
The podcast explores Regeneron's approach to tackling the challenges of GLP one medicines for obesity. George Unkoppelis from Regeneron discusses how current weight-loss medications may lead to muscle loss, emphasizing the need for solutions that preserve muscle mass while reducing body fat. Regeneron's potential cocktail of therapies, combining muscle-boosting medicine with body weight-reducing GLP one drugs, aims to address this issue and enhance the effectiveness of obesity treatments.
Feng Zhang's Personal Journey and Innovations in Biology
Feng Zhang's panel at Breakthrough Summit East reveals his unexpected journey from disliking biology in middle school to becoming a pioneer in CRISPR technology. Zhang's inspiration from 'Jurassic Park' led to groundbreaking advancements in molecular biology for treating diseases. The discussion also touches on the trend of privately financed medical institutes supporting academic researchers like Zhang in their innovative pursuits.
Challenges and Perspectives on Drug Approvals and Pricing
The podcast features intense debates on drug approvals and pricing, with a focus on balancing patient access with safety and efficacy standards. The discussions highlight the role of accelerated approvals for rare diseases and the need for post-market studies to evaluate real-world effectiveness. Participants emphasize the importance of pricing discussions for therapies with thinner evidence and the impact on patient access and affordability in the healthcare landscape.
Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode